TTD Drug ID: DAP000671

Drug Information
Name	Pentobarbital
Synonyms	Pentabarbitone; UNII-I4744080IR; DivK1c_000992; AC1L1IUE; D00499; Pentobarbitalum; Pentobarbital [USP:INN]; Spectrum5_001705; BSPBio_003305; 5-24-09-00168 (Beilstein Handbook Reference); Pentobarbital (USP/INN); Pentabarbital; Mebubarbital; Pentobarbital suppository dosage form; Pentobarbitale [DCIT]; Spectrum4_000574; HSDB 3151; Pentobarbitone; Etaminal; 5-Ethyl-5-(1-methylbutyl)malonylurea; (+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid; KBio2_004834; KBio3_002807; Spectrum2_001991; CHEMBL448; 57-33-0 (mono-hydrochloride salt); Mebumal; KBioSS_002267; Neodorm (new); Oprea1_143902; Pentobarbital (VAN); Spectrum3_001783; Pentobarbiturate; KBio2_007402; HMS2094E21; LS-24385; SPECTRUM1900006; Ethaminal; Pentobarbitale; NINDS_000992; WLN: T6VMVMV FHJ FY3&1 F2; 5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione; 5-Ethyl-5-(sec-pentyl)barbituric acid; NCGC00096074-01; MolPort-001-785-697; CCRIS 7089; SPBio_002201; C07422; 76-74-4; KBioGR_001008; Barbituric acid, 5-ethyl-5-(1-methylbutyl)-; CHEBI:7983; Nebralin; DEA No. 2270; Nembutal (TN); 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-; Pentobarbitalum [INN-Latin]; Neodorm; 5-Ethyl-5-(1-methylbutyl)barbituric acid; Spectrum_001783; 5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione; IDI1_000992; Nembutal (VAN); AKOS000277861; Aethaminalum; MolPort-003-666-760; NSC 28708; KBio1_000992; Dorsital; HMS503G05; 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione; Pentobarbital calcium; Ethyl-propylmethylcarbinylbarbituric acid; Pentobarbituric acid; DB00312; Neodorm (VAN); Rivadorm; EINECS 200-983-8; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-; Pentobarbital, Monosodium Salt; BRN 0087067; pentobarbital; KBio2_002266; AC1Q2UJM; Barbituric acid, 5-ethyl-5-(2-pentyl)-; NCGC00096074-02; Oprea1_775730; CID4737; 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; Pentobarbitone (VAN); NSC28708; Nembutal
Trade Name	Nembutal
Indication	Insomnia			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Hypnotics and Sedatives
CAS Number	CAS 76-74-4
Formular	C11H18N2O3
PubChem Compound ID	CID 4737.
PubChem Substance ID	SID 9626.
ChEBI	7983;
SuperDrug ATC ID	N05CA01;
SuperDrug CAS ID	000076744;
Target	Gamma-aminobutyric acid receptor subunit alpha-1			Antagonist	[2][3]
Ref 1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083270 To Reference
Ref 2	DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3	Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.